Pfizer starts COVID-19 vaccine trial in the US
American multinational pharmaceutical corporation Pfizer developed a vaccine in partnership with the German biotech company BioNTech. The company begins the vaccine trial in the US in an attempt to provide a quick solution for the global pandemic. Another vaccine, developed by Inovio, based on DNA technology, has also begun U.S. clinical trials.
vaccine pfizer began begins
NprRelated Articles
Moderna, Pfizer Start Decisive Covid Vaccine Trials
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday. The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration's effort to speed development of measures against the novel coronavirus.
vaccine coronavirus
Ndtv